SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
SAN DIEGO, Feb. 09, 2016 -- SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment of Laurent Combredet as President and Chief Executive Officer.
"Laurent is a well respected and strategic leader in the aesthetics dermatology field and we are excited to leverage his leadership and experience to help take the company to the next level," said Faheem Hasnain, Chairman of the Board of Directors of SENTÉ. "Laurent is a tremendous addition to SENTÉ and I look forward to his strategic insight as we further position the company to be a major contender in the aesthetics industry.”
Mr. Combredet brings to SENTÉ nearly 20 years of commercial, operations and management experience in the dermatology and consumer products industry. Most recently, Mr. Combredet was General Manager at Allergan, Medical Dermatology and Skin Care Division (including the Skinmedica line of products), where he was responsible for the management of a $700M medical grade skin care business including international operations. Previous to Allergan, Mr. Combredet was Senior Category Leader, Health and Beauty for Amazon France where he held general management positions and full P&L ownership. Mr. Combredet has also held senior commercial and marketing roles with Johnson & Johnson, Neutrogena, Gap and Clairol. He holds a Bachelor of Arts degree from George Washington University and a Masters of Business Administration from Columbia Business School.
"I am thrilled and honored to be joining SENTÉ, a company with deep experience in biotechnology that is pioneering innovative science-based skin care products with proven patient benefits,” said Mr. Combredet, President and Chief Executive Officer of SENTÉ.
About SENTÉ:
SENTÉ is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. SENTÉ is a recognized leader in the development of innovative and targeted medical skincare products based on glycosaminoglycans. Founded in 2007 and based in San Diego, California, further information may be found at http://sentelabs.com/. SENTÉ products are available through its exclusive network of physicians and medically supervised spas.
Media Contact: Creative Media Marketing Danielle Hale [email protected] p: 212.979.8884 ext. 213
